Trial intelligence / Profile preview

Caudal Epidural Prolotherapy vs Steroids for Failed Back Surgery Syndrome

NCT05548738Phase 3Completed

Sponsor
Alexandria University
Start
Apr 2022
Primary completion
Nov 2023
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of dextrose in failed back surgery syndrome (FBSS) (2 arms), sponsored by Alexandria University. Primary endpoint: Visual Analogue Scale at 2 weeks. Started Apr 2022; status: completed.

02

Drugs

dextrose
03

Conditions

failed back surgery syndrome (FBSS)

Beyond the preview

Go deeper on NCT05548738.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05548738.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call